With the US announcing fresh tariffs on branded drugs and uncertainty around H-1B visa rules, both sectors are experiencing headwinds.
The stand-off between drug makers and the trade association continues to cripple the supply of life-saving medicines. Antitrust regulator had asked the trade lobby group to stop monopolistic practices that affect the supply of essential [More]